THE SYSTEMATIC REVIEW OF SCREENING MAMMOGRAPHY BEYOND BREAST CANCER
DOI:
https://doi.org/10.61841/48scm762Keywords:
Mammography, Breast cancer, ComparrisAbstract
Background: It is critical to assess the effects of coordinated mammography service screening separately from modifications to breast cancer therapy. This can be achieved by calculating the fatal breast cancer incidence, which is determined by the diagnostic date rather than the death date.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 109 articles, whereas the results of our search on SagePub brought up 98 articles. The results of the search conducted for the last year of 2013 yielded a total 45 articles for PubMed and 32 articles for SagePub. In the end, we compiled a total of 5 papers, 4 of which came from PubMed and 1 of which came from SagePub. We included five research that met the criteria.
Conclusion: In summary, mammography screening lowers the death rate from breast cancer, although the estimates are only marginally statistically significant, the effects are modest at younger ages, and the way cases were accumulated in trials affects the outcome. Screening for cancers at higher stages also lowers the risk of cancer in those 50 and older.
References
Reeves RA, Kaufman T. Mammography. StatPearls. 2023;
Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, et al. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017;14(9):1137–43.
Rojas K, Stuckey A. Breast Cancer Epidemiology and Risk Factors. Clin Obstet Gynecol. 2016;59(4):651–72.
Mainiero MB, Moy L, Baron P, Didwania AD, diFlorio RM, Green ED. ACR Appropriateness Criteria® Breast Cancer Screening. J Am Coll Radiol. 2017;14(11):383–90.
Elkin EB, Pocus VH, Mushlin AI, Cigler T, Atoria CL, Polaneczky MM. Facilitating informed decisions about breast cancer screening: development and evaluation of a web-based decision aid for women in their 40s. BMC Med Inform Decis Mak. 2017 Mar 21;17(1).
Łuczyńska E, Heinze-Paluchowska S, Hendrick E, Dyczek S, Ryś J, Herman K, et al. Comparison between breast MRI and contrast-enhanced spectral mammography. Medical Science Monitor. 2015 May 12;21:1358– 67.
Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, et al. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection among Women with Dense Breasts Undergoing Screening. JAMA - Journal of the American Medical Association. 2020 Feb 25;323(8):746–56.
Wang Y, Li Y, Song Y, Chen C, Wang Z, Li L, et al. Comparison of ultrasound and mammography for early diagnosis of breast cancer among Chinese women with suspected breast lesions: A prospective trial. Thorac Cancer. 2022 Nov 1;13(22):3145–51.
Sun L, Qi M, Cui X, Song Q. The Clinical Application of Combined Ultrasound, Mammography, and Tumor Markers in Screening Breast Cancer among High-Risk Women. Comput Math Methods Med. 2022;2022.
Grimm LJ, Avery CS, Hendrick E, Baker JA. Benefits and Risks of Mammography Screening in Women Ages 40 to 49 Years. J Prim Care Community Health. 2022;
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
